WINNIPEG, MANITOBA--(Marketwire - November 10, 2008) - Miraculins Inc. (TSX VENTURE: MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests for unmet clinical needs, today announces a non-brokered private placement offering (the “Offering”) of up to 4,500,000 units (“Units”) at a price of $0.07 per Unit for gross proceeds of up to $315,000. Each Unit will be comprised of one common share of the Company (a “Share”) and one Share purchase warrant (a “Warrant”). Each Warrant will entitle the holder to purchase one Share at a price of $0.10 per Share for a period of 18 months from the date the Warrant is issued.
